{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:23Z","timestamp":1761129383708},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.diagmicrobio.2016.09.017","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T21:30:14Z","timestamp":1474752614000},"page":"87-91","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Differential effect of prior \u03b2-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa"],"prefix":"10.1016","volume":"87","author":[{"given":"Katie Lynn","family":"Hammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Ann","family":"Justo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brandon","family":"Bookstaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majdi N.","family":"Al-Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.amjmed.2008.03.029","article-title":"Incidence of Pseudomonas aeruginosa bacteremia: a population-based study","volume":"121","author":"Al-Hasan","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/dkp162","article-title":"Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007","volume":"64","author":"Al-Hasan","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4065\/mcp.2009.0410","article-title":"Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study","volume":"85","author":"Al-Hasan","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10096-011-1424-6","article-title":"Impact of healthcare-associated acquisition on community-onset gram-negative bloodstream infection: a population-based study","volume":"31","author":"Al-Hasan","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/1469-0691.12085","article-title":"Predictive scoring model of mortality in gram-negative bloodstream infection","volume":"19","author":"Al-Hasan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","article-title":"Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact","volume":"50","author":"Aloush","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/669865","article-title":"Escherichia coli Sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts","volume":"34","author":"Banerjee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.03935-14","article-title":"Stratification of the impact of inappropriate empirical antimicrobial therapy for gram-negative bloodstream infections by predicted prognosis","volume":"59","author":"Cain","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.amjmed.2008.03.034","article-title":"Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia","volume":"121","author":"Cheong","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13054-015-0916-7","article-title":"Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure","volume":"19","author":"Cobos-Trigueros","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0055","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/jac\/dkg201","article-title":"Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey","volume":"51","author":"Decousser","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/598640","article-title":"Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997","volume":"29","author":"Diekema","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0065","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1469-0691.1995.tb00455.x","article-title":"Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia","volume":"1","author":"Gransden","year":"1995","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2016.05.017","article-title":"Association between chronic hemodialysis and bloodstream infections due to chromosomally-mediated AmpC-producing Enterobacteriaceae","author":"Hammer","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0085","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.00060-06","article-title":"Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa","volume":"50","author":"Kaye","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0090","first-page":"22","article-title":"Mechanisms of antibiotic resistance in Pseudomonas aeruginosa","volume":"95","author":"Lambert","year":"2002","journal-title":"J R Soc Med"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CMR.00002-14","article-title":"Population-based epidemiology and microbiology of community-onset bloodstream infections","volume":"27","author":"Laupland","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/resp.12651","article-title":"Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia","volume":"21","author":"Metersky","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-015-0926-5","article-title":"An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance","volume":"19","author":"Micek","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/jac\/dkn514","article-title":"Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome","volume":"63","author":"Ortega","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s15010-009-9145-9","article-title":"Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection","volume":"38","author":"Parkins","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0120","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0125","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/AAC.00462-11","article-title":"Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis","volume":"56","author":"Retamar","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0130","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/596709","article-title":"Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?","volume":"48","author":"Schechner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ajic.2015.01.028","article-title":"Shifting trends in the incidence of Pseudomonas aeruginosa septicemia in hospitalized adults in the United States from 1996 to 2010","volume":"43","author":"Werth","year":"2015","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.diagmicrobio.2016.09.017_bb0140","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.01820-15","article-title":"Fluoroquinolone and macrolide exposure predict Clostridium difficile infection with the highly fluoroquinolone- and macrolide-resistant epidemic C. difficile strain BI\/NAP1\/027","volume":"60","author":"Wieczorkiewicz","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316303169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889316303169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T04:01:25Z","timestamp":1536379285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889316303169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0732889316303169"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.09.017","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effect of prior \u03b2-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}